ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
DOGWOOD THERAPEUTICS INC
2.64
+0.1500
6.02%
成交量:
5.86万
成交额:
15.37万
市值:
8,974.05万
市盈率:
-1.54
高:
2.77
开:
2.50
低:
2.50
收:
2.49
52周最高:
9.50
52周最低:
1.28
股本:
3,399.26万
流通股本:
580.99万
量比:
2.64
换手率:
1.01%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.7149
每股收益(LYR):
-7.1350
净资产收益率:
-47.77%
总资产收益率:
-20.83%
市净率:
1.31
市盈率(LYR):
-0.37
数据加载中...
总览
公司
新闻资讯
公告
Dogwood完成Halneuron® 2B期化疗诱发神经病变试验首批200名患者入组;关键数据预计2026年秋季公布
美股速递
·
07/20
Dogwood Therapeutics任命奥博资本风险合伙人Iain Dukes为科学顾问委员会主席
美股速递
·
06/30
Dogwood Therapeutics Inc - 扩展试验数据将支持2027年上半年三期项目向FDA提交申请
美股速递
·
05/18
Dogwood Therapeutics宣布启动Halneuron®化疗诱导神经病理性疼痛2B期长期扩展研究
美股速递
·
05/18
Dogwood Therapeutics 2026年第一季度净亏损500万美元,合每股0.15美元
美股速递
·
05/14
Dogwood Therapeutics 宣布达成历史抗病毒资产合作,潜在价值高达1亿美元
美股速递
·
05/14
Dogwood Therapeutics 达成抗病毒资产全球开发与商业化合作 潜在价值高达1亿美元
美股速递
·
04/23
Dogwood Therapeutics旗下Serpin Pharma获美国国家癌症研究所250万美元资助 用于SP16一期B阶段试验
美股速递
·
04/15
Dogwood Therapeutics与合作伙伴Serpin Pharma预计SP16药物1B期临床试验将于2026年年中启动患者招募
美股速递
·
04/15
Dogwood Therapeutics宣布FDA受理SP16研究性新药申请 用于治疗化疗引发疼痛及神经病变
美股速递
·
04/15
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/DWTX/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DWTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DWTX\",,,,,undefined,":{"symbol":"DWTX","market":"US","secType":"STK","nameCN":"DOGWOOD THERAPEUTICS INC","latestPrice":2.64,"timestamp":1787585344434,"preClose":2.49,"halted":0,"volume":58607,"delay":0,"changeRate":0.060240963855421645,"floatShares":5809900,"shares":33992600,"eps":-1.714933,"marketStatus":"交易中","change":0.15,"latestTime":"08-24 11:29:17 EDT","open":2.5,"high":2.77,"low":2.5,"amount":153722.4218734,"amplitude":0.108434,"askPrice":2.68,"askSize":134,"bidPrice":2.55,"bidSize":56,"shortable":3,"etf":0,"ttmEps":-1.714933,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"listingDate":1608181200000,"exchange":"NASDAQ","adjPreClose":2.49,"preHourTrading":{"tag":"盘前","latestPrice":2.6,"preClose":2.49,"latestTime":"09:07 EDT","volume":190,"amount":476.470068,"timestamp":1787576871550,"change":0.11,"changeRate":0.044177,"amplitude":0.040161},"postHourTrading":{"tag":"盘后","latestPrice":2.49,"preClose":2.49,"latestTime":"19:30 EDT","volume":233,"amount":579.322,"timestamp":1787355006618,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.644309},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DWTX\",,,,,undefined,":{"symbol":"DWTX","floatShares":5809900,"roa":"-20.83%","roe":"-47.77%","lyrEps":-7.13499,"volumeRatio":2.644309,"shares":33992600,"dividePrice":0,"high":2.77,"amplitude":0.108434,"preClose":2.49,"low":2.5,"week52Low":1.28,"pbRate":"1.31","week52High":9.5,"institutionHeld":0,"latestPrice":2.64,"committee":-0.410526,"eps":-1.714933,"divideRate":0,"volume":58607,"delay":0,"ttmEps":-1.714933,"open":2.5,"prevYearClose":4.16,"prevWeekClose":2.49,"prevMonthClose":1.64,"prevQuarterClose":1.61,"fiveDayClose":2.06,"twentyDayClose":1.53,"sixtyDayClose":1.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DWTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"DWTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.13,"name":null,"time":"盘前","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2026-05-14","symbol":"DWTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.22,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2026-03-18","symbol":"DWTX","fiscalQuarterEnding":"2025/12","expectedEps":-1.22,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773806400000,"reportTimeType":"pre","actualEps":-0.26},{"market":"US","date":"2025-11-06","symbol":"DWTX","fiscalQuarterEnding":"2025/09","expectedEps":-1.23,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-8.2},{"market":"US","date":"2025-08-13","symbol":"DWTX","fiscalQuarterEnding":"2025/06","expectedEps":-1.26,"name":null,"time":"盘前","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-1.99}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DWTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DWTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1745467200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DWTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DWTX","date":"2026-08-21","current":-1.507348,"percent":0.189655,"low":-5.30677,"twenty":-2.17317,"median":-0.936241,"eighty":-0.421462,"high":-0.31572,"avg":-1.309805,"sd":1.001114,"marketCap":79202648},"quantilePoints":[{"date":"2024-10-11","current":-0.88829,"twenty":-0.871777,"median":-0.847007,"eighty":-0.822237,"marketCap":4156676},{"date":"2024-10-18","current":-1.14168,"twenty":-1.243599,"median":-1.14168,"eighty":-0.919038,"marketCap":5342394},{"date":"2024-10-25","current":-1.352393,"twenty":-1.244175,"median":-1.155915,"eighty":-1.05342,"marketCap":6328406},{"date":"2024-10-31","current":-1.184386,"twenty":-1.27834,"median":-1.174407,"eighty":-1.098974,"marketCap":5542234},{"date":"2024-11-08","current":-1.035557,"twenty":-1.27834,"median":-1.184386,"eighty":-1.098974,"marketCap":5928592},{"date":"2024-11-15","current":-0.74467,"twenty":-1.269799,"median":-1.17156,"eighty":-0.88829,"marketCap":4263257},{"date":"2024-11-22","current":-0.6306,"twenty":-1.266952,"median":-1.124597,"eighty":-0.74467,"marketCap":3610202},{"date":"2024-11-29","current":-0.558465,"twenty":-1.264674,"median":-1.042032,"eighty":-0.629204,"marketCap":3197227},{"date":"2024-12-06","current":-0.532869,"twenty":-1.261826,"median":-0.94447,"eighty":-0.591959,"marketCap":3050687},{"date":"2024-12-13","current":-0.560792,"twenty":-1.247591,"median":-0.805175,"eighty":-0.586099,"marketCap":3210548},{"date":"2024-12-20","current":-0.53985,"twenty":-1.196344,"median":-0.717909,"eighty":-0.564981,"marketCap":3090652},{"date":"2024-12-27","current":-0.609658,"twenty":-1.179261,"median":-0.679489,"eighty":-0.564515,"marketCap":3490306},{"date":"2025-01-03","current":-0.584061,"twenty":-1.174695,"median":-0.665504,"eighty":-0.565461,"marketCap":3343766},{"date":"2025-01-10","current":-0.553811,"twenty":-1.172405,"median":-0.646888,"eighty":-0.565454,"marketCap":3170583},{"date":"2025-01-17","current":-0.449099,"twenty":-1.164457,"median":-0.623619,"eighty":-0.558465,"marketCap":2571103},{"date":"2025-01-24","current":-3.106463,"twenty":-1.170151,"median":-0.6306,"eighty":-0.558465,"marketCap":17784576},{"date":"2025-01-31","current":-2.969173,"twenty":-1.244175,"median":-0.653869,"eighty":-0.558465,"marketCap":16998591},{"date":"2025-02-07","current":-2.748114,"twenty":-1.269799,"median":-0.667831,"eighty":-0.560792,"marketCap":15733022},{"date":"2025-02-14","current":-1.561376,"twenty":-1.386529,"median":-0.691147,"eighty":-0.563119,"marketCap":8938914},{"date":"2025-02-21","current":-1.36824,"twenty":-1.406654,"median":-0.738827,"eighty":-0.564981,"marketCap":7833206},{"date":"2025-02-28","current":-1.095988,"twenty":-1.389852,"median":-0.805175,"eighty":-0.565476,"marketCap":6274558},{"date":"2025-03-07","current":-1.030834,"twenty":-1.384928,"median":-0.926984,"eighty":-0.569177,"marketCap":5901548},{"date":"2025-03-14","current":-1.798723,"twenty":-1.448286,"median":-1.000651,"eighty":-0.577546,"marketCap":10297735},{"date":"2025-03-21","current":-1.056947,"twenty":-1.431015,"median":-0.999453,"eighty":-0.58313,"marketCap":13053004},{"date":"2025-03-28","current":-0.925409,"twenty":-1.421838,"median":-0.979572,"eighty":-0.584992,"marketCap":11428545},{"date":"2025-04-04","current":-0.646858,"twenty":-1.406654,"median":-0.930825,"eighty":-0.586099,"marketCap":7988515},{"date":"2025-04-11","current":-0.317141,"twenty":-1.389852,"median":-0.88829,"eighty":-0.58313,"marketCap":3916603},{"date":"2025-04-17","current":-0.402359,"twenty":-1.385328,"median":-0.805724,"eighty":-0.565469,"marketCap":4969023},{"date":"2025-04-25","current":-0.61055,"twenty":-1.374755,"median":-0.785584,"eighty":-0.565469,"marketCap":7540127},{"date":"2025-05-02","current":-0.578189,"twenty":-1.358732,"median":-0.74467,"eighty":-0.568254,"marketCap":7140474},{"date":"2025-05-09","current":-0.374989,"twenty":-1.330168,"median":-0.724741,"eighty":-0.565469,"marketCap":8714743},{"date":"2025-05-16","current":-0.451467,"twenty":-1.293145,"median":-0.691147,"eighty":-0.558465,"marketCap":10492092},{"date":"2025-05-23","current":-0.435842,"twenty":-1.273215,"median":-0.667831,"eighty":-0.549157,"marketCap":10128978},{"date":"2025-05-30","current":-0.43502,"twenty":-1.26866,"median":-0.661674,"eighty":-0.542709,"marketCap":10109867},{"date":"2025-06-06","current":-0.424679,"twenty":-1.265813,"median":-0.656935,"eighty":-0.524492,"marketCap":9335860},{"date":"2025-06-13","current":-0.450325,"twenty":-1.262965,"median":-0.649201,"eighty":-0.469065,"marketCap":9899643},{"date":"2025-06-20","current":-0.417289,"twenty":-1.258453,"median":-0.635392,"eighty":-0.460532,"marketCap":9173414},{"date":"2025-06-27","current":-0.414681,"twenty":-1.246626,"median":-0.62674,"eighty":-0.450325,"marketCap":9116080},{"date":"2025-07-03","current":-0.417289,"twenty":-1.244175,"median":-0.623619,"eighty":-0.448744,"marketCap":9173414},{"date":"2025-07-11","current":-0.433807,"twenty":-1.191392,"median":-0.616057,"eighty":-0.435137,"marketCap":9536528},{"date":"2025-07-18","current":-0.413812,"twenty":-1.184386,"median":-0.61055,"eighty":-0.430908,"marketCap":9096969},{"date":"2025-07-25","current":-0.411204,"twenty":-1.175845,"median":-0.606188,"eighty":-0.428591,"marketCap":9039635},{"date":"2025-08-01","current":-0.420332,"twenty":-1.175104,"median":-0.602999,"eighty":-0.424679,"marketCap":9240303},{"date":"2025-08-08","current":-0.425287,"twenty":-1.172969,"median":-0.594948,"eighty":-0.422505,"marketCap":9349238},{"date":"2025-08-15","current":-0.380049,"twenty":-1.170151,"median":-0.588976,"eighty":-0.421636,"marketCap":9402749},{"date":"2025-08-22","current":-0.381594,"twenty":-1.165796,"median":-0.584643,"eighty":-0.419028,"marketCap":9440972},{"date":"2025-08-29","current":-0.370394,"twenty":-1.14168,"median":-0.579408,"eighty":-0.417298,"marketCap":9163858},{"date":"2025-09-05","current":-0.386229,"twenty":-1.128014,"median":-0.578189,"eighty":-0.417289,"marketCap":9555640},{"date":"2025-09-12","current":-0.378257,"twenty":-1.116602,"median":-0.565465,"eighty":-0.414688,"marketCap":9358411},{"date":"2025-09-19","current":-0.371892,"twenty":-1.1021,"median":-0.560792,"eighty":-0.413812,"marketCap":9200934},{"date":"2025-09-26","current":-0.394726,"twenty":-1.096585,"median":-0.556138,"eighty":-0.410856,"marketCap":9765864},{"date":"2025-10-03","current":-0.495918,"twenty":-1.064755,"median":-0.553811,"eighty":-0.413012,"marketCap":12269441},{"date":"2025-10-10","current":-0.519049,"twenty":-1.045015,"median":-0.552647,"eighty":-0.413742,"marketCap":12841707},{"date":"2025-10-17","current":-0.55705,"twenty":-1.036852,"median":-0.55705,"eighty":-0.413812,"marketCap":13781903},{"date":"2025-10-24","current":-0.520902,"twenty":-1.035502,"median":-0.552647,"eighty":-0.413812,"marketCap":12887570},{"date":"2025-10-31","current":-0.61637,"twenty":-1.031765,"median":-0.55705,"eighty":-0.414507,"marketCap":15249527},{"date":"2025-11-07","current":-0.481974,"twenty":-1.007156,"median":-0.555431,"eighty":-0.414681,"marketCap":11924442},{"date":"2025-11-14","current":-0.327725,"twenty":-1.000768,"median":-0.549157,"eighty":-0.413742,"marketCap":12520664},{"date":"2025-11-21","current":-0.357136,"twenty":-0.998735,"median":-0.545565,"eighty":-0.409242,"marketCap":13644313},{"date":"2025-11-28","current":-0.391355,"twenty":-0.987046,"median":-0.544503,"eighty":-0.403493,"marketCap":14951645},{"date":"2025-12-05","current":-0.368541,"twenty":-0.971236,"median":-0.53985,"eighty":-0.398837,"marketCap":14080014},{"date":"2025-12-12","current":-4.995522,"twenty":-0.987046,"median":-0.53985,"eighty":-0.39658,"marketCap":190852899},{"date":"2025-12-19","current":-4.746524,"twenty":-1.032696,"median":-0.544503,"eighty":-0.398429,"marketCap":181339982},{"date":"2025-12-26","current":-3.40816,"twenty":-1.050981,"median":-0.545001,"eighty":-0.398837,"marketCap":130208053},{"date":"2026-01-02","current":-3.236974,"twenty":-1.111477,"median":-0.549157,"eighty":-0.39905,"marketCap":123667922},{"date":"2026-01-09","current":-2.451074,"twenty":-1.16928,"median":-0.552647,"eighty":-0.399948,"marketCap":93642777},{"date":"2026-01-16","current":-2.351299,"twenty":-1.182678,"median":-0.557977,"eighty":-0.400578,"marketCap":89830899},{"date":"2026-01-23","current":-2.578032,"twenty":-1.247239,"median":-0.558465,"eighty":-0.402359,"marketCap":98493164},{"date":"2026-01-30","current":-2.435274,"twenty":-1.269799,"median":-0.561956,"eighty":-0.404249,"marketCap":93039145},{"date":"2026-02-06","current":-2.662007,"twenty":-1.36824,"median":-0.565484,"eighty":-0.407726,"marketCap":101701410},{"date":"2026-02-13","current":-2.536044,"twenty":-1.420694,"median":-0.572344,"eighty":-0.408596,"marketCap":96889041},{"date":"2026-02-20","current":-2.536071,"twenty":-1.540898,"median":-0.574661,"eighty":-0.409242,"marketCap":96890059},{"date":"2026-02-27","current":-2.405345,"twenty":-1.831766,"median":-0.578189,"eighty":-0.409453,"marketCap":91895726},{"date":"2026-03-06","current":-2.492496,"twenty":-2.234293,"median":-0.579338,"eighty":-0.410856,"marketCap":95225281},{"date":"2026-03-13","current":-2.623221,"twenty":-2.344581,"median":-0.583582,"eighty":-0.413012,"marketCap":100219614},{"date":"2026-03-20","current":-2.638773,"twenty":-2.411331,"median":-0.585772,"eighty":-0.413742,"marketCap":90397426},{"date":"2026-03-27","current":-2.028037,"twenty":-2.43626,"median":-0.591133,"eighty":-0.413812,"marketCap":69475230},{"date":"2026-04-02","current":-2.076788,"twenty":-2.435274,"median":-0.593369,"eighty":-0.413812,"marketCap":71145307},{"date":"2026-04-10","current":-1.930536,"twenty":-2.417317,"median":-0.597275,"eighty":-0.414333,"marketCap":66135074},{"date":"2026-04-17","current":-1.521028,"twenty":-2.400116,"median":-0.605004,"eighty":-0.414681,"marketCap":52106422},{"date":"2026-04-24","current":-1.365025,"twenty":-2.394624,"median":-0.608494,"eighty":-0.414681,"marketCap":46762174},{"date":"2026-05-01","current":-1.394276,"twenty":-2.368094,"median":-0.611014,"eighty":-0.414686,"marketCap":47764220},{"date":"2026-05-08","current":-1.521028,"twenty":-2.346261,"median":-0.615922,"eighty":-0.415207,"marketCap":52106422},{"date":"2026-05-15","current":-1.930536,"twenty":-2.342443,"median":-0.621292,"eighty":-0.416072,"marketCap":66135074},{"date":"2026-05-22","current":-2.134847,"twenty":-2.337557,"median":-0.626653,"eighty":-0.416941,"marketCap":60456810},{"date":"2026-05-29","current":-1.969721,"twenty":-2.321068,"median":-0.62867,"eighty":-0.417289,"marketCap":55780593},{"date":"2026-06-05","current":-1.981516,"twenty":-2.281465,"median":-0.637581,"eighty":-0.417289,"marketCap":56114609},{"date":"2026-06-12","current":-1.851774,"twenty":-2.23843,"median":-0.653869,"eighty":-0.417289,"marketCap":52440438},{"date":"2026-06-18","current":-1.757416,"twenty":-2.210516,"median":-0.657312,"eighty":-0.417291,"marketCap":49768313},{"date":"2026-06-26","current":-1.757537,"twenty":-2.179667,"median":-0.663177,"eighty":-0.41747,"marketCap":49771738},{"date":"2026-07-02","current":-1.781287,"twenty":-2.170232,"median":-0.667831,"eighty":-0.418159,"marketCap":50444329},{"date":"2026-07-10","current":-1.67441,"twenty":-2.158437,"median":-0.69531,"eighty":-0.419028,"marketCap":47417669},{"date":"2026-07-17","current":-1.626909,"twenty":-2.134847,"median":-0.732985,"eighty":-0.419028,"marketCap":46072487},{"date":"2026-07-24","current":-1.828788,"twenty":-2.113794,"median":-0.753635,"eighty":-0.419028,"marketCap":51789511},{"date":"2026-07-31","current":-1.876289,"twenty":-2.111765,"median":-0.785584,"eighty":-0.419723,"marketCap":53134693},{"date":"2026-08-07","current":-2.078168,"twenty":-2.116169,"median":-0.805724,"eighty":-0.420245,"marketCap":58851717},{"date":"2026-08-14","current":-2.351299,"twenty":-2.160796,"median":-0.905302,"eighty":-0.42068,"marketCap":66586514},{"date":"2026-08-21","current":-2.197553,"twenty":-2.17317,"median":-0.936241,"eighty":-0.421462,"marketCap":79202648}],"updateTime":1787580879639},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DWTX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1113001000","title":"Dogwood完成Halneuron® 2B期化疗诱发神经病变试验首批200名患者入组;关键数据预计2026年秋季公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1113001000","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113001000?lang=zh_cn&edition=fundamental","pubTime":"2026-07-20 20:32","pubTimestamp":1784550725,"startTime":"0","endTime":"0","summary":"在针对化疗诱发神经病变的Halneuron® 2B期临床试验中,Dogwood Therapeutics已成功完成首批200名患者的入组工作。这项持续进行的试验预计将在2026年秋季获得关键性数据结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DWTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153907881","title":"Dogwood Therapeutics任命奥博资本风险合伙人Iain Dukes为科学顾问委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1153907881","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153907881?lang=zh_cn&edition=fundamental","pubTime":"2026-06-30 20:46","pubTimestamp":1782823577,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc. 宣布了一项重要人事任命,Iain Dukes 将担任其科学顾问委员会主席一职。Dukes 先生目前是知名投资机构奥博资本的风险合伙人,他在生物技术和生命科学领域拥有深厚的专业背景与丰富的行业经验。此次任命旨在进一步加强 Dogwood Therapeutics 的科学战略指导与研发能力。公司期望借助 Dukes 先生在药物开发、企业战略及投资方面的专长,加速其治疗管线的推进,并为未来的科学决策提供关键洞见。Dukes 先生的加入,预计将为 Dogwood Therapeutics 带来更广阔的行业视野和战略资源。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DWTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137042063","title":"Dogwood Therapeutics Inc - 扩展试验数据将支持2027年上半年三期项目向FDA提交申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1137042063","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137042063?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 20:46","pubTimestamp":1779108396,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc 宣布,其扩展试验数据将为公司在2027年上半年向美国食品药品监督管理局(FDA)提交三期项目申请提供关键支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122519246","title":"Dogwood Therapeutics宣布启动Halneuron®化疗诱导神经病理性疼痛2B期长期扩展研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1122519246","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122519246?lang=zh_cn&edition=fundamental","pubTime":"2026-05-18 20:45","pubTimestamp":1779108321,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc. 已正式启动其候选药物Halneuron®针对化疗诱导的神经病理性疼痛(CINP)的2B期长期扩展研究。\n这项扩展研究旨在评估Halneuron®在更长时间周期内的安全性与有效性,将为该药物的长期治疗潜力提供关键数据。神经病理性疼痛是癌症患者化疗后常见的严重副作用,目前临床需求远未得到满足。\n公司此举标志着Halneuron®临床开发项目进入新阶段,有望为遭受化疗相关疼痛困扰的患者带来新的治疗选择。研究进展将受到投资者与医疗界的密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159504779","title":"Dogwood Therapeutics 2026年第一季度净亏损500万美元,合每股0.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159504779","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159504779?lang=zh_cn&edition=fundamental","pubTime":"2026-05-14 20:35","pubTimestamp":1778762111,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc公布2026年第一季度财务业绩,归属于普通股股东的净亏损为500万美元,摊薄后每股亏损0.15美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DWTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141459489","title":"Dogwood Therapeutics 宣布达成历史抗病毒资产合作,潜在价值高达1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141459489","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141459489?lang=zh_cn&edition=fundamental","pubTime":"2026-05-14 20:34","pubTimestamp":1778762087,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc 宣布,已就一批历史抗病毒资产达成一项合作协议。该合作潜在价值最高可达1亿美元,标志着公司在盘活非核心资产、挖掘其潜在价值方面取得了重要进展。此次合作旨在通过外部专业力量,进一步开发这些资产的商业潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DWTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191715043","title":"Dogwood Therapeutics 达成抗病毒资产全球开发与商业化合作 潜在价值高达1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1191715043","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191715043?lang=zh_cn&edition=fundamental","pubTime":"2026-04-23 21:01","pubTimestamp":1776949299,"startTime":"0","endTime":"0","summary":"DOGWOOD THERAPEUTICS INC 近日宣布,已就旗下抗病毒资产达成一项全球范围内的开发与商业化战略合作伙伴关系。此次合作蕴含巨大潜力,其总价值有望攀升至1亿美元,标志着公司在抗病毒治疗领域迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DWTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176419965","title":"Dogwood Therapeutics旗下Serpin Pharma获美国国家癌症研究所250万美元资助 用于SP16一期B阶段试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1176419965","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176419965?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 21:15","pubTimestamp":1776258902,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc旗下子公司Serpin Pharma近日宣布,已获得美国国家癌症研究所(National Cancer Institute)提供的250万美元资助。该项资金将专项用于支持SP16药物的一期B阶段临床试验(Phase 1B Trial)的推进工作。\n该资助标志着SP16在肿瘤治疗领域的研发取得重要进展。一期B阶段试验将重点评估SP16在特定患者群体中的安全性、耐受性及初步疗效,为后续临床研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158453332","title":"Dogwood Therapeutics与合作伙伴Serpin Pharma预计SP16药物1B期临床试验将于2026年年中启动患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1158453332","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158453332?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 21:07","pubTimestamp":1776258439,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics Inc及其合作伙伴Serpin Pharma近日宣布,针对SP16药物的1B期临床试验预计将于2026年中期正式启动患者招募工作。这一重要进展标志着该创新疗法在临床开发道路上迈出关键一步。\n两家公司透露,此次临床试验将重点评估SP16在特定患者群体中的安全性和有效性。该时间节点的确定基于前期研究数据的积极反馈以及监管沟通的顺利推进。研究人员表示,这一里程碑事件将为后续临床开发计划奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183833289","title":"Dogwood Therapeutics宣布FDA受理SP16研究性新药申请 用于治疗化疗引发疼痛及神经病变","url":"https://stock-news.laohu8.com/highlight/detail?id=1183833289","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183833289?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 21:02","pubTimestamp":1776258152,"startTime":"0","endTime":"0","summary":"Dogwood Therapeutics公司宣布,美国食品药品监督管理局(FDA)已正式受理其SP16研究性新药(IND)申请。该申请旨在探索SP16用于治疗化疗引起的疼痛和神经病变的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DWTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}